| Lisa Lynn Lyons, MD | |
|
2800 10th Ave S Ste 2200, Hospital Pathology Assoc, Minneapolis, MN 55407-1311 | |
| (612) 767-8370 | |
| (612) 767-8376 |
| Full Name | Lisa Lynn Lyons |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 25 Years |
| Location | 2800 10th Ave S Ste 2200, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598758658 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 46581 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Allina United Hospital | Saint paul, MN | Hospital |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Mercy Hospital | Coon rapids, MN | Hospital |
| Buffalo Hospital | Buffalo, MN | Hospital |
| Cuyuna Regional Medical Center | Crosby, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital Pathology Associates, Pa | 2668464652 | 43 |
News Archive
The Guardian examines China's one-child policy and its impact. The newspaper writes that "the description of the system as a 'one-child policy' is misleading. Most married women in China have the chance to bear two offspring, but the entitlement to breed beyond a solitary child is determined by a complex set of rules" and factors.
Michael F. Holick, PhD, MD, director of the General Clinical Research Center and professor of medicine, physiology and biophysics at Boston University School of Medicine, is this year's recipient of The Delbert A. Fisher Research Scholar Award from the Endocrine Society for his scholarly work on the history of endocrinology.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma.
A single treatment of 8 gray (Gy-a unit of measure of absorbed radiation dose) of radiation appears to be as effective in palliating painful bone metastases as the current U.S. standard treatment course of 30 Gy delivered in 10 daily treatments, according to a new study in the June 1 issue of the Journal of the National Cancer Institute.
› Verified 6 days ago
| Entity Name | Hospital Pathology Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033173182 PECOS PAC ID: 2668464652 Enrollment ID: O20040331000680 |
News Archive
The Guardian examines China's one-child policy and its impact. The newspaper writes that "the description of the system as a 'one-child policy' is misleading. Most married women in China have the chance to bear two offspring, but the entitlement to breed beyond a solitary child is determined by a complex set of rules" and factors.
Michael F. Holick, PhD, MD, director of the General Clinical Research Center and professor of medicine, physiology and biophysics at Boston University School of Medicine, is this year's recipient of The Delbert A. Fisher Research Scholar Award from the Endocrine Society for his scholarly work on the history of endocrinology.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma.
A single treatment of 8 gray (Gy-a unit of measure of absorbed radiation dose) of radiation appears to be as effective in palliating painful bone metastases as the current U.S. standard treatment course of 30 Gy delivered in 10 daily treatments, according to a new study in the June 1 issue of the Journal of the National Cancer Institute.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Lynn Lyons, MD 2800 10th Ave S Ste 2200, Hospital Pathology Assoc, Minneapolis, MN 55407-1311 Ph: (612) 767-8370 | Lisa Lynn Lyons, MD 2800 10th Ave S Ste 2200, Hospital Pathology Assoc, Minneapolis, MN 55407-1311 Ph: (612) 767-8370 |
News Archive
The Guardian examines China's one-child policy and its impact. The newspaper writes that "the description of the system as a 'one-child policy' is misleading. Most married women in China have the chance to bear two offspring, but the entitlement to breed beyond a solitary child is determined by a complex set of rules" and factors.
Michael F. Holick, PhD, MD, director of the General Clinical Research Center and professor of medicine, physiology and biophysics at Boston University School of Medicine, is this year's recipient of The Delbert A. Fisher Research Scholar Award from the Endocrine Society for his scholarly work on the history of endocrinology.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma.
A single treatment of 8 gray (Gy-a unit of measure of absorbed radiation dose) of radiation appears to be as effective in palliating painful bone metastases as the current U.S. standard treatment course of 30 Gy delivered in 10 daily treatments, according to a new study in the June 1 issue of the Journal of the National Cancer Institute.
› Verified 6 days ago
Khalid Amin, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 420 Delaware St Se, C463 Mayo Memorial Bldg, Mayo Mail Code 76, Minneapolis, MN 55455 Phone: 913-827-3505 | |
Dr. Laura L Schmitz, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3300 Oakdale Ave N, Minneapolis, MN 55422 Phone: 763-581-4150 Fax: 763-581-4151 | |
Dr. Michael Patrick Greenwood, MD Pathology Medicare: Medicare Enrolled Practice Location: 909 Fulton St Se, Minneapolis, MN 55455 Phone: 612-672-7422 | |
Deborah Elizabeth Powell, MD Pathology Medicare: Medicare Enrolled Practice Location: 500 Harvard St Se, Lab Med & Pathology, Minneapolis, MN 55455 Phone: 612-273-1142 | |
Yiang Hui, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave S Ste 2200, Minneapolis, MN 55407 Phone: 612-767-8373 | |
Dr. Pamela Ann Sakkinen, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave S Ste 2200, Hospital Pathology Assoc, Minneapolis, MN 55407 Phone: 612-767-8370 Fax: 612-767-8376 | |
Kevin Todd Stieglbauer, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave S Ste 2200, Hospital Pathology Assoc, Minneapolis, MN 55407 Phone: 612-767-8370 Fax: 612-767-8376 |